Want to see DOC full AI Analyst Report?
Net Income by Segment
Shows profit or loss after all expenses and non‑operating items for each segment. Variations can reflect operating performance, property sales, or one‑time charges, so this helps identify which segments are actually contributing to reported earnings versus being affected by accounting or transaction noise.Outpatient medical and senior housing have shifted from background contributors to the primary drivers of net income growth—outpatient acceleration reflects strong leasing fundamentals while senior housing flipped to sustained profitability following the Janus Living IPO (monetization optionality and eventual ~ $0.04/sh accretion). Lab remains the noisy swing factor—historical one‑offs and a sharp 2025 Q3 hit highlight downside from softer re‑leasing spreads. Corporate costs and upcoming refinancing (mid‑2026 maturities) are the main near‑term earnings drags to monitor.
Date | Corporate | Outpatient Medical | Lab | Senior Housing | Other |
|---|---|---|---|---|---|
Jun 30, 2026 | -$110.94M | $72.91M | $63.15M | $14.86M | $23.28M |
Mar 31, 2026 | -$107.75M | $161.68M | $101.66M | $27.87M | $16.19M |
Dec 31, 2025 | -$109.43M | $116.10M | $80.96M | $18.49M | $15.66M |
Sep 30, 2025 | -$91.03M | $64.95M | -$104.19M | $4.44M | $15.98M |
Jun 30, 2025 | -$100.91M | $54.40M | $74.33M | $303.00K | $10.91M |
Mar 31, 2025 | -$98.88M | $51.22M | $80.40M | -$1.68M | $19.00M |
Dec 31, 2024 | -$81.24M | $32.07M | $83.31M | -$25.98M | $2.52M |
Sep 30, 2024 | -$96.92M | $94.96M | $85.24M | -$2.83M | $12.28M |
Jun 30, 2024 | -$102.73M | $108.59M | $138.83M | -$160.00K | $8.20M |
Mar 31, 2024 | -$200.41M | $49.68M | $169.80M | -$2.17M | -$5.72M |